Medical Journals

High-density Lipoprotein Hydrolysis by Endothelial Lipase Activates Pparalpha: a Candidate Mechanism for High-density Lipoprotein-mediated Repression of Leukocyte Adhesion.

Authors:
  • Ahmed Waleed
  • Orasanu Gabriela
  • Nehra Vedika
  • Asatryan Liana
  • Rader Daniel J
  • Ziouzenkova Ouliana
  • Plutzky Jorge

From: Donald W. Reynolds Cardiovascular Clinical Research Center, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MAUSA.

Circulation research

  • Publish Date: Mar 2006
  • ISSN: 1524-4571
  • Volume: 98
  • Issue: 4
  • Pages: 490-8
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Ahmed Waleed, Orasanu Gabriela, Nehra Vedika, et al. High-density Lipoprotein Hydrolysis by Endothelial Lipase Activates Pparalpha: a Candidate Mechanism for High-density Lipoprotein-mediated Repression of Leukocyte Adhesion.. Circ. Res. Mar 2006;98:490-8

Abstract

Although high-density lipoprotein (HDL) is known to inhibit endothelial adhesion molecule expression, the mechanism for this anti-inflammatory effect remains obscure. Surprisingly, we observed that HDL no longer decreased adhesion of U937 monocytoid cells to tumor necrosis factor (TNF)alpha-stimulated human endothelial cells (EC) in the presence of the general lipase inhibitor tetrahydrolipstatin. In considering endothelial mechanisms responsible for this effect, we found that endothelial lipase (EL) overexpression in both EC and non-EL-expressing NIH/3T3 mouse embryonic fibroblasts cells significantly decreased TNFalpha-induced VCAM1 expression and promoter activity in a manner dependent on HDL concentration and intact EL activity. Given recent evidence for lipolytic activation of peroxisome proliferator-activated receptors (PPARs)-nuclear receptors implicated in metabolism, atherosclerosis, and inflammation-we hypothesized HDL hydrolysis by EL is an endogenous endothelial mechanism for PPAR activation. In both EL-transfected NIH cells and bovine EC, HDL significantly increased PPAR ligand binding domain activation in the order PPAR-alpha> >-gamma>-delta. Moreover, HDL stimulation induced expression of the canonical PPARalpha-target gene acyl-CoA-oxidase (ACO) in a PPARalpha-dependent manner in ECs. Conditioned media from EL-adenovirus transfected cells but not control media exposed to HDL also activated PPARalpha. PPARalpha activation by EL was most potent with HDL as a substrate, with lesser effects on LDL and VLDL. Finally, HDL inhibited leukocyte adhesion to TNFalpha-stimulated ECs isolated from wild-type but not PPARalpha-deficient mice. This data establishes HDL hydrolysis by EL as a novel, distinct natural pathway for PPARalpha activation and identifies a potential mechanism for HDL-mediated repression of VCAM1 expression, with significant implications for both EL and PPARs in inflammation and vascular biology.

Mesh Headings (Keywords): Acyl-CoA Oxidase, Animals, Cattle, Cell Adhesion, Cells, Cultured, Dose-Response Relationship, Drug, Gene Expression Regulation, Humans, Hydrolysis, Leukocytes, Lipase, Lipolysis, Lipoproteins, HDL, Mice, PPAR alpha, Tumor Necrosis Factor-alpha, Vascular Cell Adhesion Molecule-1


Check for Full Text / PubMed Unique Identifier (PMID): 16439686


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.